{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:34:18Z","timestamp":1770485658192,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jsbmb.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T15:30:42Z","timestamp":1368113442000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause"],"prefix":"10.1016","volume":"138","author":[{"given":"Mikko","family":"Unkila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seppo","family":"Kari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emrah","family":"Yatkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risto","family":"Lammintausta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2013.04.004_bib0005","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro","year":"2009","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/clpt.2010.161","article-title":"Progress and prospects in treating postmenopausal vaginal atrophy","volume":"89","author":"Winneker","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0020","first-page":"3090","article-title":"Diagnosis and treatment of atrophic vaginitis","volume":"61","author":"Bachmann","year":"2000","journal-title":"American Family Physician"},{"issue":"Suppl 3","key":"10.1016\/j.jsbmb.2013.04.004_bib0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1743-6109.2005.00131.x","article-title":"Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women","volume":"2","author":"Goldstein","year":"2005","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0030","first-page":"228","article-title":"Postmenopausal vaginal atrophy and atrophic vaginitis","volume":"314","author":"Pandit","year":"1997","journal-title":"The American Journal of the Medical Sciences"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.maturitas.2008.01.004","article-title":"Estrogen receptor (ER) and ER-related receptor expression in normal and atrophic human vagina","volume":"59","author":"Cavallini","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0040","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1067\/mob.2001.119627","article-title":"Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women","volume":"185","author":"Gebhart","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0045","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2174\/092986707780598023","article-title":"Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs)","volume":"14","author":"Musa","year":"2007","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1258\/175404507780456791","article-title":"The future of the new selective estrogen receptor modulators","volume":"13","author":"Palacios","year":"2007","journal-title":"Menopause International"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/pr.58.4.8","article-title":"International Union of Pharmacology. LXIV. Estrogen receptors","volume":"58","author":"Dahlman-Wright","year":"2006","journal-title":"Pharmacologocal Reviews"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/CIA.S6083","article-title":"Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene","volume":"5","author":"Gennari","year":"2010","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00002512-200724050-00002","article-title":"Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development","volume":"24","author":"Gennari","year":"2007","journal-title":"Drugs and Aging"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0075","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1021\/jm970167b","article-title":"Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]benzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator","volume":"40","author":"Palkowitz","year":"1997","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0080","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2008.20.5179","article-title":"American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction","volume":"27","author":"Visvanathan","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1358\/dot.2009.45.7.1395293","article-title":"Bazedoxifene acetate: a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis","volume":"45","author":"Chines","year":"2009","journal-title":"Drugs of Today (Barcelona, Spain: 1998)"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/13543780902953715","article-title":"Ospemifene use in postmenopausal women","volume":"18","author":"Gennari","year":"2009","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0095","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/endo.141.2.7342","article-title":"Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats","volume":"141","author":"Qu","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/(SICI)1097-4644(19990615)73:4<500::AID-JCB8>3.0.CO;2-E","article-title":"Comparative effects of estrogen and antiestrogens on differentiation of osteoblasts in mouse bone marrow culture","volume":"73","author":"Qu","year":"1999","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jsbmb.2005.06.027","article-title":"Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice","volume":"97","author":"Wurz","year":"2005","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/WHE.09.31","article-title":"Advances in the treatment of menopausal symptoms","volume":"5","author":"Pinkerton","year":"2009","journal-title":"Womens Health (London, England)"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00042192-200512020-00015","article-title":"Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women","volume":"12","author":"Komi","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy","author":"Portman","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jsbmb.2005.02.018","article-title":"Effects of dehydroepiandrosterone, Premarin and Acolbifene on histomorphology and sex steroid receptors in the rat vagina","volume":"96","author":"Berger","year":"2005","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0190","doi-asserted-by":"crossref","unstructured":"A. Tolonen, P. Koskimies, M. Turpeinen, J. Uusitalo, R. Lammintausta, O. Pelkonen, Ospemifene metabolism in humans in vitro and in vivo: metabolite identification, quantitation, and CYP assignment of major hydroxylations, Drug Metabolism and Drug Interactions (2013) Epublished ahead of print.","DOI":"10.1515\/dmdi-2013-0016"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0960-0760(98)00147-2","article-title":"An estrogen receptor basis for raloxifene action in bone","volume":"69","author":"Bryant","year":"1999","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0140","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1210\/en.2003-1481","article-title":"Long-term treatment of lasofoxifene preserves bone mass and bone strength and does not adversely affect the uterus in ovariectomized rats","volume":"145","author":"Ke","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0145","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/en.2005-0030","article-title":"Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity","volume":"146","author":"Komm","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0150","article-title":"One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus","author":"Simon","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.maturitas.2007.07.005","article-title":"Effects of tibolone and raloxifene on health-related quality of life and sexual function","volume":"58","author":"Nijland","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1095\/biolreprod48.1.205","article-title":"Immunocytochemical localization of progesterone receptor in the reproductive tract of adult female rats","volume":"48","author":"Ohta","year":"1993","journal-title":"Biology and Reproduction"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/gcen.1999.7333","article-title":"Distribution of progesterone receptor in female mouse tissues","volume":"115","author":"Uotinen","year":"1999","journal-title":"General and Comparative Endocrinology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1432-0436.1994.5630143.x","article-title":"Expression of keratins in mouse vaginal epithelium","volume":"56","author":"Gimenez-Conti","year":"1994","journal-title":"Differentiation"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0175","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.ju.0000137744.12814.2e","article-title":"Modulation of rat vaginal blood flow and estrogen receptor by estradiol","volume":"172","author":"Kim","year":"2004","journal-title":"Journal of Urology"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0180","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.gme.0000227337.73738.c9","article-title":"Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats","volume":"13","author":"Wang","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.04.004_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1755-8794-1-27","article-title":"Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman","volume":"1","author":"Jelinsky","year":"2008","journal-title":"BMC Medical Genomics"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:42:49Z","timestamp":1760744569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076013000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":38,"alternative-id":["S0960076013000654"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.04.004","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}